CVS Health Files 2023 10-K, Details Financial Performance
Ticker: CVS · Form: 10-K · Filed: 2024-02-07T00:00:00.000Z
Sentiment: neutral
Topics: earnings, annual-report, financial-performance
TL;DR
**CVS's 2023 10-K is out, giving a full financial picture for the year.**
AI Summary
CVS Health Corp. filed its 10-K on February 7, 2024, for the fiscal year ending December 31, 2023. This filing provides a comprehensive look at the company's financial performance, including product and service revenues for 2023, 2022, and 2021, and details on common stock, treasury stock, and retained earnings as of December 31, 2023. This matters to investors because it offers transparency into CVS's financial health and operational trends, helping them assess the company's stability and future growth potential.
Why It Matters
This filing provides crucial financial data, allowing investors to evaluate CVS Health's past performance and make informed decisions about their investment.
Risk Assessment
Risk Level: medium — The filing provides standard financial disclosures, indicating a stable, established company, but doesn't highlight any immediate, severe risks or opportunities.
Analyst Insight
Investors should review the detailed financial statements within the full 10-K to understand revenue trends for products and services, and changes in equity, to assess CVS Health's financial stability and growth prospects.
Key Numbers
- 2023-12-31 — Fiscal Year End (The date the financial reporting period concluded for this 10-K.)
- 2024-02-07 — Filing Date (The date the 10-K was officially filed with the SEC.)
- 0000064803 — Central Index Key (CIK) (Unique identifier for CVS Health Corp. with the SEC.)
- 173 — Public Document Count (The total number of documents included in this filing.)
- 001-01011 — SEC File Number (The SEC registration number for CVS Health Corp.)
Key Players & Entities
- CVS HEALTH Corp (company) — the company filing the 10-K
- 0000064803 (dollar_amount) — Central Index Key (CIK) for CVS HEALTH Corp
- 20231231 (date) — Conformed Period of Report end date
- 20240207 (date) — Filed As Of Date
- ONE CVS DR., WOONSOCKET, RI 02895 (company) — CVS Health's business address
Forward-Looking Statements
- CVS Health will continue to focus on its core retail-drug store and proprietary store operations. (CVS HEALTH Corp) — high confidence, target: 2024-12-31
- The company's financial reporting will remain consistent with US GAAP standards. (CVS HEALTH Corp) — high confidence, target: 2024-12-31
FAQ
What is the filing date for CVS Health Corp.'s 10-K?
The 10-K for CVS Health Corp. was filed on February 7, 2024, as indicated by the 'FILED AS OF DATE: 20240207'.
What is the fiscal year-end for the period covered by this 10-K?
The fiscal year-end for the period covered by this 10-K is December 31, 2023, as stated in 'CONFORMED PERIOD OF REPORT: 20231231'.
What is CVS Health Corp.'s Central Index Key (CIK) according to this filing?
CVS Health Corp.'s Central Index Key (CIK) is 0000064803, as listed under 'CENTRAL INDEX KEY: 0000064803'.
Where is CVS Health Corp.'s business address located?
CVS Health Corp.'s business address is ONE CVS DR., WOONSOCKET, RI 02895, as detailed in the 'BUSINESS ADDRESS' section of the filing.
What was CVS Health Corp.'s former name before CVS/CAREMARK CORP?
Before CVS/CAREMARK CORP, the company's former name was CVS CORP, with a date of name change on 19970128, as indicated in the 'FORMER COMPANY' section.
From the Filing
0000064803-24-000007.txt : 20240207 0000064803-24-000007.hdr.sgml : 20240207 20240207065235 ACCESSION NUMBER: 0000064803-24-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 173 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 24602075 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 10-K 1 cvs-20231231.htm 10-K cvs-20231231 0000064803 2023 FY false http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201812Member P3Y 0 http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations P3Y P6M 0000064803 2023-01-01 2023-12-31 0000064803 2023-06-30 iso4217:USD 0000064803 2024-01-31 xbrli:shares 0000064803 us-gaap:ProductMember 2023-01-01 2023-12-31 0000064803 us-gaap:ProductMember 2022-01-01 2022-12-31 0000064803 us-gaap:ProductMember 2021-01-01 2021-12-31 0000064803 2022-01-01 2022-12-31 0000064803 2021-01-01 2021-12-31 0000064803 us-gaap:ServiceMember 2023-01-01 2023-12-31 0000064803 us-gaap:ServiceMember 2022-01-01 2022-12-31 0000064803 us-gaap:ServiceMember 2021-01-01 2021-12-31 iso4217:USD xbrli:shares 0000064803 2023-12-31 0000064803 2022-12-31 0000064803 2021-12-31 0000064803 2020-12-31 0000064803 us-gaap:CommonStockMember 2020-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2020-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-12-31 0000064803 us-gaap:RetainedEarningsMember 2020-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000064803 us-gaap:ParentMember 2020-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2020-12-31 0000064803 2020-01-01 2020-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember 2020-12-31 0000064803 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:ParentMember 2020-12-31 0000064803 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember 2020-12-31 0000064803 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000064803 us-gaap:ParentMember 2021-01-01 2021-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000064803 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0000064803 us-gaap:CommonStockMember 2021-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2021-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-12-31 0000064803 us-gaap:RetainedEarningsMember 2021-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000064803 us-gaap:ParentMember 2021-12-31 0